Analysis of:
ECTRMS: Family History Worsens MS Severity (www.medpagetoday.com)
The MS research team at UCSF is one of the most authoritative and reliable groups in the world and Dr. Zivdanov is a prominent research neurologist. This study provides valuable insights on the genetics of MS.
Analysis of:
Painkiller Widely Abused in South (www.washingtonpost.com)
The article describes the increase in hydrocodone abuse, especially in the Southern and Rural US.
Analysis of:
American's Gamble for Bargain Surgery Abroad (www.medpagetoday.com)
The article describes several examples of medical tourism with different motivations and risks involved.
Analysis of:
Oncoscience AG, the european partner of YM BioSciences, announces completion of patient enrollment in phase III brain cancer trial of nimotuzab (www.pipelinereview.com)
The articel discusses Oncoscience AG, the european partner of YM BioSciences experimenal treatment for gliomas. It is based on a monoclonal antibody to EGFR and is being tested in combination with other treatments including radiation.
Analysis of:
New Treatment Boosts Muscle Function In Myasthenia Gravis (www.medicalnewstoday.com)
The article reports on an open label study recently published in Neurology. Apparently a new treatment (oral EN101 antisense) appears to be effective at improving muscle strength and reducing fatigue in people with MG.
Analysis of:
Genetic breakthrough offers MS sufferers hope of new treatment (www.timesonline.co.uk)
Two genes have been linked to an increased risk for the development of MS. Several researchers speculate on the ipact this may have on future treatments.
Analysis of:
Industry Fights Switch to Generics for Epilepsy (online.wsj.com)
The epilepsy foundation and major drug manufacturers have teamed up to protect reimbursments for branded anti-epilepsy drugs.
Analysis of:
Industry Fights Switch to Generics for Epilepsy (online.wsj.com)
The epilepsy foundation and major drug manufacturers have teamed up to protect reimbursments for branded anti-epilepsy drugs.
Analysis of:
Multi MERCI(R) Trial Demonstrates Better Outcomes For Patients Suffering Ischemic Stroke (www.medicalnewstoday.com)
The article reports on the results of recent research showing the effectiveness of the Merci(R) Retrieval System. This pivotal study has contributed to the device receiving FDA approval
Analysis of:
Aspect Medical Systems' psych treatment (biotech.seekingalpha.com)
I agree with Dr Martin, but it should also be noted that the "science" of using EEG to assess response to meds for psychiatric diseases (as opposed to epilepsy) typically uses quantitative and averaging methods, rather than raw data. The nature of EEG is dynamic and brief segmental...